Product Information
NYSTATIN-TRIAMCINOLONE OINTM is a generic product labeled by Encube Ethicals, Inc., priced at $0.3448 per GM under NDC 21922003104. Its NADAC has been published 362 times since Oct 30, 2019.
FDA first approved this application on Jan 31, 2017. Its Orange Book therapeutic-equivalence code is AT.
Strength
100000; 1 [USP'U]/g; mg/g
Manufacturer
Encube Ethicals, Inc.NDC
21922003104
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
NYSTATIN; TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207741FDA Approved
1/31/2017
TE Code
AT
On Market Since
9/28/2019
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN-TRIAMCINOLONE OINTM has been published 362 times since Oct 30, 2019, and over the history we have for it it has declined 30.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3448 per GM |
|---|---|
| All-time high | $0.6644 (Nov 11, 2020) |
| All-time low | $0.2317 (May 22, 2024) |
| 52-week high | $0.3643 |
| 52-week low | $0.2997 |
| Median price | $0.3720 |
| Average price | $0.4094 |
| Largest weekly change | +51.9% (Jun 19, 2024) |
| Weeks tracked | 362 |
| Tracking since | Oct 30, 2019 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 45% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Encube Ethicals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nystatin and Triamcinolone Acetonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NYSTATIN-TRIAMCINOLONE OINTM?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN-TRIAMCINOLONE OINTM, manufactured by Encube Ethicals, Inc., is $0.3448 per GM (NDC 21922003104), effective Sep 30, 2026.
How has the price of NYSTATIN-TRIAMCINOLONE OINTM changed over time?
Over the history we have for it, the NADAC for NYSTATIN-TRIAMCINOLONE OINTM has declined 30.4%. It has been tracked across 362 weekly CMS publications since Oct 30, 2019.
What are the highest and lowest recorded NADAC prices for NYSTATIN-TRIAMCINOLONE OINTM?
Since Oct 30, 2019, the NADAC for NYSTATIN-TRIAMCINOLONE OINTM has ranged from a low of $0.2317 (May 22, 2024) to a high of $0.6644 (Nov 11, 2020), with a median of $0.3720 per GM.
Are there cheaper alternatives to NYSTATIN-TRIAMCINOLONE OINTM?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYSTATIN-TRIAMCINOLONE OINTM, is $0.1910 per GM — about 45% below NYSTATIN-TRIAMCINOLONE OINTM.
Who manufactures NYSTATIN-TRIAMCINOLONE OINTM?
NYSTATIN-TRIAMCINOLONE OINTM (NDC 21922003104) is labeled by Encube Ethicals, Inc., and CMS classifies it as a generic product.